| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392510A1 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2388678A1 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/07/2001 | CA2388559A1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/06/2001 | EP1104811A1 HBV sequences |
| 06/06/2001 | EP1104770A2 Compositions and methods for detecting and treating acquired immunodeficiency syndrome |
| 06/06/2001 | EP1104767A1 Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| 06/06/2001 | EP1104676A1 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/06/2001 | EP1104470A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 06/06/2001 | EP1104442A1 Papillomavirus cellular receptor |
| 06/06/2001 | EP1104441A1 Hiv suppressor factor derived from scrub typhus |
| 06/06/2001 | EP1104310A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 06/06/2001 | EP1104308A1 Antibodies for use in targeted and temporary treatment of humans and animals |
| 06/06/2001 | EP1104307A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/06/2001 | EP1104306A1 Compositions of cpg and saponin adjuvants and methods thereof |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0579626B1 Method and agents for promoting wound healing |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298446A Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298308A Inhibitors of complement activation |
| 06/06/2001 | CN1298307A Enhancement of immunity by intranasal inoculation of IL-12 |
| 06/06/2001 | CN1297776A Medicine for resisting acute exclusiveness and raising activity level of complement during organ transplantation |
| 06/05/2001 | US6242666 Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 06/05/2001 | US6242580 Single-chain forms of the glycoprotein hormone quartet |
| 06/05/2001 | US6242578 Glycoconjugate of carbohydrate covalently bound to peptide of defined amino acid sequence; prevention of influenza virus binding to cells, treatment of schizophrenia, and diagnosis of chronic viral diseases related to cancer |
| 06/05/2001 | US6242567 Amino acid sequences of hexapeptide, heptapeptide, and polypeptides from late 64 kilodalton protein; diagnosis; vaccines |
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242564 Administering peptide of defined amino acid sequence |
| 06/05/2001 | US6242426 Induction of immune response to antigens expressed by recombinant adeno-associated virus |
| 06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242213 Nucleotide sequences coding preferential polypeptide for use in controlling immune response |
| 06/05/2001 | US6242179 Nucleotide sequences coding eukaryotic hydrolase; for the diagnosis, prevention, and treatment of immune defects and cancers; anticarcinogenic agents |
| 06/05/2001 | US6242176 Preventing viral joining to cells; incubation of cells with ligand and screen for deactivation of viral activity |
| 06/05/2001 | US6241995 Polygala senega compositions and methods of use |
| 06/05/2001 | US6241991 Aviadenovirus |
| 06/05/2001 | US6241990 Immunogenic composition containing inactivated swine infertility and respiratory Syndrome virus |
| 06/05/2001 | US6241989 Recombinant multivalent viral vaccine |
| 06/05/2001 | US6241985 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 06/05/2001 | US6241983 Bacteria-and fiber-containing composition for human gastrointestinal health |
| 06/05/2001 | US6241982 Method for treating brain cancer with a conditionally lethal gene |
| 06/05/2001 | US6241961 Administering to bone marrow of patient a dose of a monoclonal antibody or antibody fragment stably coupled to a cadmium-66 radioisotope; side effect reduction |
| 06/05/2001 | CA2112408C Monoclonal antibody to lymphocyte-associated cell surface protein |
| 06/05/2001 | CA1341245C Recombinant vaccinia virus mva |
| 06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
| 05/31/2001 | WO2001038499A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | WO2001038498A2 A new genotype of hepatitis b virus |
| 05/31/2001 | WO2001038497A1 Duck pneumovirus and corresponding vaccines |
| 05/31/2001 | WO2001038494A1 Method of proliferating natural killer cells |
| 05/31/2001 | WO2001038490A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038394A2 Polypetptides and methods for thymic vaccination |
| 05/31/2001 | WO2001038362A2 Production of vaccines |
| 05/31/2001 | WO2001038360A2 Novel hcv non-structural polypeptide |
| 05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
| 05/31/2001 | WO2001038352A2 Methods of inhibiting metastasis |
| 05/31/2001 | WO2001038350A2 85kDa NEISSERIAL ANTIGEN |
| 05/31/2001 | WO2001038338A1 Synthetic oligomannosides, preparation and uses thereof |
| 05/31/2001 | WO2001037872A1 'bonzo' chemokine receptor antibodies and ligands |
| 05/31/2001 | WO2001037870A1 Treatment of autoimmune diseases by an agonistic cd40-binding protein |
| 05/31/2001 | WO2001037869A1 Vaccine compositions |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037866A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037863A2 Compositions comprising neisseria meningitidis antigens from serogroups b and c as well as a further antigen |
| 05/31/2001 | WO2001037862A2 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias |
| 05/31/2001 | WO2001037860A1 Method of inducing immune tolerance |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037848A1 Mixture of pomegranate seed oil and juice products |
| 05/31/2001 | WO2001037821A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | WO2001037671A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | WO2000077188A3 Dna pcv vaccine |
| 05/31/2001 | WO2000072880A3 Prevention and treatment of amyloidogenic disease |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000055345A3 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 05/31/2001 | WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/31/2001 | WO2000000617A3 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 05/31/2001 | WO1999062923A3 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 05/31/2001 | WO1999060124A3 Differentiation-associated sequences and methods of use therefor |
| 05/31/2001 | WO1999054479A3 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | US20010002256 Multicomponent clostridial vaccines using saponin adjuvants |